Last edition
News about "NK-1 receptor antagonist"
Vanda Pharmaceuticals Launches NEREUS (tradipitant) for Motion Sickness in US
Vanda Pharmaceuticals launches NEREUS (tradipitant), the first new motion sickness treatment in over 40 years, now available in the US with direct ordering via nereus.us.
NK-1 Receptor Antagonist | 04/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members